“Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors vs. syringes: an online questionnaire-based study in patients with migraine” (2025) Confinia Cephalalgica, 34(2). doi:10.4081/cc.2024.15772.